by c4cfadmin | Oct 22, 2026 | News, Research
Cure4CF Update Cure4CF and Lung Foundation Australia announce new partnership Cure4CF and Lung Foundation Australia are partnering to turbo charge respiratory research. This new three-year partnership brings together two highly respected national organisations with...
by c4cfadmin | Oct 9, 2026 | News, Research
Cure4CF Update Don’t Fear the GLP-1RA: Follow the Science What a new cystic fibrosis study tells us Professor Jodie Simpson You can’t scroll through the news or social media without seeing something about GLP-1RA medicines. They’re miracle drugs....
Cure4CF is proud to join forces with Lung Foundation Australia (LFA) to strengthen research into bronchiectasis – a chronic lung disease that affects many in our cystic fibrosis (CF) community.
A new Australian study explores whether GLP-1 medicines could improve lung function in people with cystic fibrosis-related diabetes. What the research tells us, and why more studies are needed.
Recent Comments